LTLorna E. Thorpe

Lorna E. Thorpe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lorna E. Thorpe has a total of 472 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Glucosuria as a Marker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Real-World Practice

    by Zongpu Li, Aditya Surapaneni, David M. Charytan, Leora I. Horwitz, Saul Blecker, Jung-Im Shin, Lorna E. Thorpe, Michal L. Melamed, Morgan E. Grams

    Key Points: Glucosuria is a proxy for adherence to sodium-glucose cotransporter 2 (SGLT2) inhibitors. Patients with glucosuria during SGLT2 inhibitor prescriptions have lower risk of mortality, heart failure, and kidney failure. Background: Medication nonadherence contributes to the efficacy–effectiveness gap in real-world practice. Glucosuria, routinely measured on urinalysis, may serve as an objective proxy for assessing medication adherence to sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of medications that reduce the risks of kidney disease, heart failure, and mortality. Methods: We leveraged 2 cohorts from the Optum Labs Data Warehouse real-world data (2014–2023): cohort 1 included 3987 patients with SGLT2 inhibitor pharmacy claims and a urinalysis performed both before and during active fill periods; cohort 2 included 45,711 patients prescribed SGLT2 inhibitors with urinalysis performed within 6 months after initiation. Glucosuria was defined as urine glucose 2+ or greater. Cohort 2 was followed for a mean of 3.3 years for all-cause mortality, heart failure hospitalization, and kidney failure; fractures were used as a negative control outcome. Results: In cohort 1, SGLT2 inhibitor use (versus no use) was associated with 18.1-fold higher odds of glucosuria (95% confidence interval [CI], 16.4 to 20.0), adjusted for diabetes status. In cohort 2, 26,657 (58%) had glucosuria within 6 months of SGLT2 inhibitor initiation, suggesting adherence. After inverse probability of treatment weighting, glucosuria was associated with lower risks of all-cause mortality (hazard ratio [HR], 0.78; 95% CI, 0.73 to 0.83), heart failure hospitalization (HR, 0.87; 95% CI, 0.78 to 0.98), and kidney failure (HR, 0.73; 95% CI, 0.58 to 0.91) compared with no glucosuria. No association was observed with fractures (HR, 1.00; 95% CI, 0.95 to 1.06). Conclusions: Glucosuria was associated with SGLT2 inhibitor adherence and, among patients prescribed SGLT2 inhibitors, is associated with reductions in risks of all-cause mortality, heart failure, and kidney failure.

  • Open Access

    Neighborhood Built Environments and Chronic Kidney Disease Risk in US Veterans Across Urbanicity

    by Byoungjun Kim, Jongsoo Hong, Andrea R. Titus, Rania Kanchi, Myeonggyun Lee, David C. Lee, JungHo Park, Jose O. Aleman, Jay Pendse, Josef Coresh, et al.

    Background: Chronic kidney disease (CKD) prevalence shows substantial geographic variation, suggesting that neighborhood built-environment factors, such as food environments and walkability, may be associated with the incidence risk. Study Design: A retrospective cohort study. Setting & Participants: A national cohort of 3,953,165 US veterans without CKD at baseline, enrolled January 2009–December 2017, and followed through December 2019. Exposures: Time-dependent densities of fast-food restaurants, grocery stores, convenience stores, and walkability components (densities of retail stores, street network, public transit, and park availability), natural-log transformed. Outcome: Incident CKD, defined as two eGFR values <60 mL/min/1.73 m² or albumin-to-creatinine ratio ≥30 mg/g separated by ≥90 days, or relevant ICD-9/10 codes. Analytical Approach: Cox proportional hazards regression models with time-dependent covariates, stratified by urbanicity (urban, suburban, rural), adjusted for age, sex, race/ethnicity, marital status, enrollment priority group, homelessness, housing insecurity, and ZIP-Code-level poverty. Results: Among 3,953,165 veterans (mean age 58.7 years; 93.8% male), 874,298 (22.1%) developed CKD. Higher fast-food density (log-count/mi²) was associated with greater CKD risk, with the strongest association in rural areas (aHR, 1.44; 95% CI, 1.32–1.58). Higher grocery store density was associated with lower CKD risk, particularly in rural areas (aHR, 0.83; 95% CI, 0.79–0.88). Convenience store density was associated with higher CKD risk in suburban (aHR, 1.10; 95% CI, 1.06–1.13) and rural areas (aHR, 1.18; 95% CI, 1.11–1.24). Greater park access in urban settings (aHR, 0.76; 95% CI, 0.71–0.82) and higher retail density in rural settings (aHR, 0.87; 95% CI, 0.84–0.89) were associated with lower CKD risk. Limitations: Findings may not generalize to non-veteran populations; potential for residential address misclassification. Conclusions: Neighborhood food environment and walkability characteristics were associated with CKD risk, with the pattern of associations varying across levels of urbanicity. Tailored place-based interventions (e.g., improving healthy food access in rural areas and enhancing park access in urban settings) may help reduce CKD burden.

  • Open Access

    Associations between Residential Mobility and All-Cause Mortality Among Adults in Primary Care: A National Cohort Study

    by Jongsoo Hong, Rania Kanchi, Andrea R. Titus, Myeonggyun Lee, Samrachana Adhikari, David C. Lee, Josef Coresh, Morgan E. Grams, Scott Sherman, Lorna E. Thorpe, et al.

    Background: Residential mobility is common, but whether moving is associated with mortality, and whether this depends on move distance and destination deprivation, is unclear. Prior studies, largely using move/no-move measures, have reached conflicting conclusions. Methods: In a retrospective national cohort of 7 100 986 adults in the US Veterans Health Administration (VHA), 2011–2024 (mean follow-up 9.5 years), we characterised mobility from quarterly geocoded addresses by cumulative frequency, geographic scale (within-tract to out-of-state), and change in census-tract Neighbourhood Deprivation Index (NDI), and estimated associations with all-cause mortality using marginal structural models with stabilised inverseprobability-of-treatment weights, adjusting for baseline and time-varying confounders. Results: Of 7 100 986 adults, 4 528 530 (63.8%) relocated. The association with mortality was heterogeneous by move type: a first within-tract move was associated with higher mortality (hazard ratio [HR] 1.81, 95% CI 1.80–1.81), whereas out-of-state moves were associated with lower mortality (HR 0.76, 95% CI 0.76–0.77). Moves into more-deprived neighbourhoods were associated with higher mortality (HR 1.09 to 1.22 across one to three or more moves) and moves into less-deprived neighbourhoods with lower mortality, in a dose–response pattern. Associations were consistent across subgroups, with the within-tract excess greatest among adults experiencing homelessness or housing insecurity. Conclusions: Residential mobility was associated with all-cause mortality, but not uniformly: shorter-distance moves and moves into more-deprived neighbourhoods with higher mortality, longer-distance moves and moves into less-deprived neighbourhoods with lower mortality. The health implications of moving depend on the type of move rather than on moving alone.

  • Open Access

    Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes

    by Sharine Wittkopp, Parsa Asachi, Filipp Kazatsker, Souptik Barua, José O. Alemán, Terry Gordon, Robert D. Brook, Lorna E. Thorpe, Jonathan D. Newman

    • 1 July 2026
      • Vol. 116  (7) , 887-889

    Approaches to Approximating National Public Health Data.

    by Ben R Spoer, Lorna E Thorpe, Marc N Gourevitch

  • Public Trust, Private Data: Four Considerations for the Future of Health

    by Nabarun Dasgupta, Jennifer D. Schoendorf, Denys T. Lau, Lorna Thorpe

  • Open Access

    Evaluating Methods for Imputing Race and Ethnicity in Electronic Health Record Data

    by Sarah Conderino, Jasmin Divers, John A. Dodson, Lorna E. Thorpe, Mark G. Weiner, Samrachana Adhikari

    Objective: To compare anonymized and non‐anonymized approaches for imputing race and ethnicity in descriptive studies of chronic disease burden using electronic health record (EHR)‐based datasets.Study Setting and Design: In this New York City‐based study, we first conducted simulation analyses under different missing data mechanisms to assess the performance of Bayesian Improved Surname Geocoding (BISG), single imputation using neighborhood majority information, random forest imputation, and multiple imputation with chained equations (MICE). Imputation performance was measured using sensitivity, precision, and overall accuracy; agreement with self‐reported race and ethnicity was measured with Cohen's kappa (κ). We then applied these methods to impute race and ethnicity in two EHR‐based data sources and compared chronic disease burden (95% CIs) by race and ethnicity across imputation approaches.Data Sources and Analytic Sample: Our data sources included EHR data from NYU Langone Health and the INSIGHT Clinical Research Network from 3/6/2016 to 3/7/2020 extracted for a parent study on older adults in NYC with multiple chronic conditions.Principal Findings: Under simulation analyses, the non‐anonymized BISG imputation provided the most accurate classification of race and ethnicity, ranging from 66% to 73% across missing data mechanisms. Anonymized imputation methods were more sensitive to the missing data mechanism, with agreement dropping when race and ethnicity was missing not at random (MNAR) (κ single = 0.25, κ MICE = 0.25, κ randomforest = 0.33). When these methods were applied to the NYU and INSIGHT cohorts, however, racial and ethnic distributions and chronic disease burden were consistent across all imputation methods. Slight improvements in the precision of estimates were observed under all imputation approaches compared to a complete case analysis.Conclusions: BISG imputation may provide a more accurate racial and ethnic classification than single or multiple imputation using anonymized covariates, particularly if the missing data mechanism is MNAR. Descriptive studies of disease burden may not be sensitive to methods for imputing missing data.


  • Open Access

    Emulating a Target Trial to Evaluate the Impact of Empiric Antimicrobial Strategies on Mortality in Enterococcal Bloodstream Infections

    by Juan E Gago, Victor J Torres, Bo Shopsin, Lorna E Thorpe

    Background: Enterococcal bloodstream infections (BSI) caused by Enterococcus faecalis and Enterococcus faecium pose substantial clinical and public health challenges, especially amid rising vancomycin resistance (VRE). Empiric regimens initiated before pathogen identification may lead to suboptimal coverage. We aimed to estimate the causal effect of two empiric strategies (immediate VRE coverage (daptomycin or linezolid) versus initial vancomycin or ampicillin with the option to escalate) by emulating a target trial using electronic health records. Methods: We identified adults (18+ years) with positive blood cultures for E. faecalis or E. faecium between January 2017 and January 2023. Patients had data compatible with : (1) immediate assignment to VRE coverage on day 0, or (2) initial VSE active therapy on day 0 with potential escalation within three days if clinical deterioration (e.g., ICU admission) or new microbiologic data warranted. We adjusted for baseline confounders (age, sex, Charlson comorbidity index, prior antibiotic use, immunosuppression) and for time varying factors (change in severity) using inverse probability weighting (IPW). We estimated both intention to treat (ITT) and per protocol effects on 30 day all cause mortality; sensitivity analyses assessed 10 and 15 day mortality for early outcome detection. Results: Among 799 patients, 45 (5.6%) received VRE targeted therapy at baseline; the remainder started on VSE active agents. The ITT analysis suggested that universal immediate VRE coverage would reduce 30 day mortality by 1.35 percentage points (95% CI: -7.2% to 7.9%), while the per protocol analysis yielded a risk difference of -3.76 points (95% CI: -14.9% to 20.4%). Sensitivity analyses of early mortality showed similarly null estimated. Conclusions: These results indicate clinical equipoise between immediate VRE coverage and a standard approach with potential escalation, with no clear survival benefit from empirical broad spectrum therapy in this setting. Further studies, prefereably randomized trials or emulation of them with larger datasets, remain necessary to better understand potential benefits in changing empiric treatment protocols for enterococcal BSI.

  • Open Access

    Opportunities and Challenges in Using Electronic Health Record Systems to Study Postacute Sequelae of SARS-CoV-2 Infection: Insights From the NIH RECOVER Initiative

    by Hannah L Mandel, Shruti N Shah, L Charles Bailey, Thomas Carton, Yu Chen, Shari Esquenazi-Karonika, Melissa Haendel, Mady Hornig, Rainu Kaushal, Carlos R Oliveira, et al.

    The benefits and challenges of electronic health records (EHRs) as data sources for clinical and epidemiologic research have been well described. However, several factors are important to consider when using EHR data to study novel, emerging, and multifaceted conditions such as postacute sequelae of SARS-CoV-2 infection or long COVID. In this article, we present opportunities and challenges of using EHR data to improve our understanding of long COVID, based on lessons learned from the National Institutes of Health (NIH)–funded RECOVER (REsearching COVID to Enhance Recovery) Initiative, and suggest steps to maximize the usefulness of EHR data when performing long COVID research.